OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-03-31-accounts

Stem cell and bone marrow transplants are now regularly used as curative treatments for patients with blood cancer (such as lymphoma, myeloma and leukaemia). Yet 4 in 5 patients from black, Asian, mixed-heritage or other minority ethnic groups are unable to find a donor match.

Race Against Blood Cancer works to increase the total number of people on the stem cell and bone marrow register, with a particular emphasis on increasing the level of sign up from minority groups – whether defined by race, ethnicity or gender – who are vastly underrepresented on the donor registry at present. Our vision is that one day, all blood cancer patients will have the equal opportunity of a quality stem cell match.

We have a simple overarching strategy to deliver on our vision:

  1. Raise awareness of the underrepresentation issue and improve apathy;

  2. Educate people on the process of becoming a donor and demystifying the many myths that currently exist; and

  3. Help simplify the donor sign up process, making it more accessible for everyone.

The Trustees of Race Against Blood Cancer are pleased to present our Annual Report which covers the financial year 1st April 2020 to 31st March 2021. This reporting period proved to be more difficult than ever due to the worldwide Covid-19 pandemic. In-person donor recruitment was not possible for much of the year, which had a significant impact on our performance.

However, due to our efforts of previous years, some of our potential stem cell donors continued to be matched to patients in need, with the charity now responsible for 16 stem cell transplants from the pool of nearly 10,000 donors that we have recruited.

Employees

General Manager Julie Child

Julie is supported by a number of committed individuals who work for the charity on a freelance basis; Gemma Elsmore, our Engagement Co-ordinator for Shropshire and Alex Morrison, our Engagement Co-ordinator for London. Emma Brown, our Social Media Manager was replaced by a new Communications Officer, Tess Suleman, at the start of the new financial year. The Trustees would like to thank Emma for all the support she has given to the charity since it was established.

Due to the Covid-19 pandemic, Julie was furloughed for a considerable proportion of the financial year in order to protect the dwindling of precious reserves given the downturn in donor recruitment activities.

In addition to our paid staff, we are ably supported by a number of volunteers who assist with our finance administration and donor recruitment events. Our grateful thanks must go to this group for their commitment to the charity; they are instrumental to our current and future success.

Achievements and performance

Race Against Blood Cancer is a registered charity number 1162696 Registered office address: 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ

Donor recruitment

Due to the pandemic, all face to face donor recruitment events stopped for several months and we were only able to carry out two no-contact donor drives in the year. However, we continued to recruit online with our existing registry partner, DKMS, as well as setting up a new partnership with Anthony Nolan in order to share patient stories with a view to recruiting to their register.

In addition to the cancellation of existing events, we also had to deal with the postponement of other areas of our work including putting our pilot project – the West Midlands Community Engagement Manager role – on hold and having significant delays to the Wellcome Trust funded research project led by Dr Ros Williams at the University of Sheffield (https://mixandmatch.blog/).

Although 85% of our recruitment was carried out via the internet, we did manage to recruit nearly 200 new donors throughout the year, as well developing our networks within the industry further. As a direct result of this work, the charity became a founder member of the NBTA (National BAME Transplant Alliance) sub-committee on stem cell donation. This group, which consists of a number of charities as well as all four UK donor registries, is expected to have a significant role in developing a national donor recruitment strategy for people from black, Asian, mixed-heritage and minority ethnic communities over the next few years.

Fundraising

Unfortunately, like many small charities, fundraising during this financial year was extremely difficult. The highly anticipated cycle event with Carl Ikeme and Joleon Lescott was postponed several times due to Covid-19 restrictions , though the desire is still there from all concerned to hold a cycle event at a later date.

The charity was fortunate to benefit from a £20,000 grant from The People’s Postcode Trust towards the West Midlands Community Engagement pilot project and we will commence this project as soon as circumstances permit. During the year, we benefitted from some pro-bono support from the Oxford University Student Consultancy group who were able to produce a significant amount of supporting research which we can use when this project gets underway.

Whilst the London Marathon didn’t go ahead as planned and was postponed until 2021, our ballot place holder, Vicky Thompson did an incredible job in dealing with this disappointment and still ran 26.2 miles to raise funds for the charity.

Acknowledgements

The Trustees would like to thank the following individuals, companies and charitable trusts for their support:

Anthony Nolan

Beth Elsmore

Carl Ikeme

DKMS UK

Dr Ros Williams

Ian Leech

Joleon Lescott

Maria Gardner

Race Against Blood Cancer is a registered charity number 1162696 Registered office address: 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ

Max Fitzgerald

Ribble Cycles

Sam Westwood

Stolen Goat The Oxford Student Consultancy Group

The People’s Postcode Trust

The Roger Counter Foundation

Vicky Thompson Wolverhampton Wanderers FC

Race Against Blood Cancer is a registered charity number 1162696 Registered office address: 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ

Race Against Blood Cancer

Charity No. 1162696

Company No. CE005053

Trustees' Report and Unaudited Accounts

31 March 2021

Race Against Blood Cancer Contents

Pages
Trustees' Annual Report 2 to 3
Independent Examiner's Report 4
Statement of Financial Activities 5
Summary Income and Expenditure Account 6
Balance Sheet 7
Statement of Cash flows 8
Notes to the Accounts 9 to 15
Detailed Statement of Financial Activities 16 to 17

Page 1

Race Against Blood Cancer Trustees Annual Report

The Trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the unaudited financial statements of the charity for the year ended 31 March 2021.

REFERENCE AND ADMINISTRATIVE DETAILS

Company No. CE005053

Charity No. 1162696

Registered Office

71-75 Shelton Street Covent Garden London WC2H 9JQ

Directors and Trustees

The Directors of the charitable company are its Trustees for the purposes of charity law. The following Directors and Trustees served during the year:

J. Bates J. Cook (Resigned 9 January 2021) G. Fiske M.M. Gardner H. Shah B. Westwood

Directors of Corporate Trustees

Directors of Corporate Trustees
J Cook (Treasurer Resigned 9
M M Gardner (Custodian) January 2021 ) B Westwood(Trustee)
H Shah(Treasurer Appointed 15
G Fisk (Custodian) J Bates (Chairman) Mach 2021)

Accountants

Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield HD1 5JL

Page 2

Race Against Blood Cancer Trustees Annual Report

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Companies Act 2006. The Trustees are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006 and in accordance with the Charities SORP (FRS 102).

Signed on behalf of the board

Joe Bates

Joe Bates (Jan 5, 2022 15:46 GMT)

J. Bates Trustee 20 December 2021

Page 3

Race Against Blood Cancer Independent Examiners Report

Independent Examiner's Report to the trustees of Race Against Blood Cancer

I report to the charity trustees on my examination of the accounts of Race Against Blood Cancer for the year ended 31 March 2021 which comprise the Statement of Financial Activities, the Summary Income and Expenditure Account, the Balance Sheet, the Statement of Cash Flows and the related notes.

Responsibilities and basis of report

As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act.

Having satisfied myself that the accounts of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I can confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Solutions Accountancy & Bookkeeping Ltd 1 The Mews Little Brunswick Street Huddersfield

HD1 5JL 20 December 2021

Page 4

Race Against Blood Cancer Statement of Financial Activities

for the year ended 31 March 2021

Notes
Income and endowments
from:
Donations and legacies
4
Other
5
Total
Expenditure on:
Raising funds
6
Other
7
Total
Net gains on investments
Net income/(expenditure)
Transfers between funds
Net income/(expenditure)
before other gains/(losses)
Other gains and losses
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward		 Unrestricted
funds
2021
£
18,828
16,341		 Restricted
funds
2021
£
20,000
-		 Total funds
2021
£
38,828
16,341		 Total funds
2020
£
62,552
-
35,169
2,016
32,366		 20,000
-
-		 55,169
2,016
32,366		 62,552
19,058
44,000
34,382
-		 -
-		 34,382
-		 63,058
-
787
18,015		 20,000
-		 20,787
18,015		 (506)
-
18,802 20,000 38,802 (506)
18,802
(5,489)		 20,000
18,015		 38,802
12,526		 (506)
19,925
13,313 38,015 51,328 19,419

Page 5

Race Against Blood Cancer Summary Income and Expenditure Account for the year ended 31 March 2021

Income
Gross income for the year
Expenditure
Total expenditure for the year
Net income/(expenditure) before tax
for the year
Net income /(expenditure )for the year		 2021
£
55,169
55,169
34,382
34,382
20,787
20,787		 2020
£
62,552
62,552
63,058
63,058
(506)
(506)

Page 6

Race Against Blood Cancer Balance Sheet

at 31 March 2021

Company No.
CE005053
Notes
2021
£
Current assets
Cash at bank and in hand
65,253
65,253
Creditors:Amount falling due within one year
9
(1,925)
Net current assets
63,328
Total assets less current liabilities
63,328
Creditors:Amounts falling due after more than one year
10
(12,000)
Provisions for liabilities
11
-
Net assets excluding pension asset or liability
51,328
Total net assets
51,328
The funds of the charity
Restricted funds
12
Restricted income funds
38,015
38,015
Unrestricted funds
12
General funds
13,313
13,313
Reserves
12
Total funds
51,328		 2020
£
31,484
31,484
(943)
30,541
30,541
-
(18,015)
12,526
12,526
18,015
18,015
(5,489)
(5,489)
12,526

These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

For the year ended 31 March 2021 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

Approved by the board on 20 December 2021

And signed on its behalf by:

Joe Bates

Joe Bates (Jan 5, 2022 15:46 GMT)

J. Bates Trustee

20 December 2021

Page 7

Race Against Blood Cancer Statement of Cash flows for the year ended 31 March 2021

Cash flows from operating activities
Net income/(expenditure) per Statement of Financial Activities
Adjustments for:
Movement in provisions
Government JRS Grant
(Decrease)/Increase in trade and other payables
Net cash provided by operating activities
Cash flows from investing activities
Government JRS Grant
Net cash from investing activities
Cash flows from financing activities
Repayment of borrowings
Net cash from financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Components of cash and cash equivalents
Cash and bank balances		 2021
£
38,802
(18,015)
(16341)
(2,018)
2,428
16,341
16,341
15,000
15,000
33,769
31,484
65,253
65,253
65,253		 2020
£
(7,399)
18,015
-
943
11,559
-
-
-
-
11,559
37,940
49,499
31,484
31,484

Page 8

Race Against Blood Cancer Notes to the Accounts

for the year ended 31 March 2021

Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Change in basis of accounting or to previous accounts

There has been no change to the accounting policies (valuation rules and method of accounting) since last year and no changes have been made to accounts for previous years.

Fund accounting

Income

Volunteer help The value of any volunteer help received is not included in the accounts. Investment income This is included in the accounts when receivable. Gains/(losses) on This includes any gain or loss resulting from revaluing investments to market value revaluation of fixed at the end of the year. assets Gains/(losses) on This includes any gain or loss on the sale of investments. investment assets

Page 9

Race Against Blood Cancer Notes to the Accounts

Expenditure

Taxation

The charity is exempt from corporation tax on its charitable activities.

Freehold investment property

Investment properties are measured initially at cost and subsequently at fair value at each balance sheet date and are not depreciated. All gains or losses are taken to the Statement of Financial Activities as they arise.

Stocks

Stock is included at the lower of cost or net realisable value. Donated items of stock are recognised at fair value which is the amount the charity would have been willing to pay for the items on the open market.

Trade and other debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. In the statement of financial position, bank overdrafts are shown within borrowings or current liabilities. In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the company's cash management.

Trade and other creditors

Short term creditors are measured at the transaction price. Other creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

Page 10

Race Against Blood Cancer Notes to the Accounts

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Foreign currencies

Monetary assets and liabilities denominated in currencies other than the functional currency of the charity are translated at the rates of exchange prevailing at the end of the reporting period.

Transactions in currencies other than the functional currency of the charity are recorded at the rate of exchange on the date that the transaction occurred.

All exchange differences are are taken into account in arriving at net income/expenditure.

Leased assets

Where the charity enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.

Leases which do not transfer substantially all the risks and rewards of ownership to charity are classified as operating leases.

Assets held under finance leases are initially recognised as assets of the charity at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the charity's policy on borrowing costs.

Assets held under finance leases are depreciated in the same way as owned assets.

Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.

Pension costs

The charity operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.

Receipt of donated goods, facilities and services

All donated goods, facilities and services received are recognised within incoming resources and expenditure at an estimate of the value to the charity.

2 Company status

The company is a private company limited by guarantee and consequently does not have share capital.

Page 11

Race Against Blood Cancer Notes to the Accounts

3 Statement of Financial Activities - prior year

3
Statement of Financial Activities - prior year
Income and endowments from:
Donations and legacies
Total
Expenditure on:
Raising funds
Other
Total
Net income
Transfers between funds
Net income before other
gains/(losses)
Other gains and losses:
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
4
Income from donations and legacies
Adhoc Donations MyDonate
Donations From Events
General Donations
Regular Donations
5
Other income
Government JRS Grant		 Unrestricted
£
1
10,463
8,212
152
18,828		 Unrestricted
funds
2020
£
44,537
44,537
19,058
44,000
63,058
(18,521)
(6,893)
(25,414)
(25,414)
37,940
12,526
Restricted
£
-
-
20,000
-
20,000
Unrestricted
£
16,341
16,341		 Restricted
funds
2020
£
18,015
18,015
-
-
-
18,015
-
18,015
18,015
-
18,015
Total
2021
£
1
10,463
28,212
152
38,828
Total
2021
£
16,341
16,341		 Total funds
2020
£
62,552
62,552
19,058
44,000
63,058
(506)
(6,893)
(7,399)
(7,399)
37,940
30,541
Total
2020
£
70
25,398
33,969
3,115
62,552
Total
2020
£
-
-

Page 12

Race Against Blood Cancer Notes to the Accounts

6 Expenditure on raising funds

Costs of generating voluntary
income
Adhoc Donations MyDonate
Donations From Events
7
Other expenditure
Employee costs
General administrative costs
Legal and professional costs
8
Staff costs
Salaries and wages
Social security costs
Pension costs
No employee received emoluments in excess of £60,000.
9
Creditors:
amounts falling due within one year
Bank loans and overdrafts
Other taxes and social security
Other creditors		 Unrestricted
£
1,457
559
2,016
Unrestricted
£
26,517
2,544
3,305
32,366
25,924
-
593
26,517
2021
£
3,000
(1,206)
131
1,925		 Total
2021
£
1,457
559
2,016
Total
2021
£
26,517
2,544
3,305
32,366		 Total
2020
£
1,783
17,275
19,058
Total
2020
£
36,035
2,726
5,239
44,000
32,255
3,030
750
36,035
2020
£
-
780
163
943
10 Creditors:
amounts falling due after more than one year
Bank loans and overdrafts		 2021
£
12,000
12,000		 2020
£
-
-

Page 13

Race Against Blood Cancer Notes to the Accounts

11 Provisions

Provisions
Onerous Total
contracts
£ £
At 1 April 2020 18,015 18,015
Movement for the year (18,015) (18,015)

12 Movement in funds

12 Movement in funds
At 1 April
2020
500
15,000
1,000
1,000
210
200
105
-
18,015
(5,489)
12,526		 Incoming
resources
(including
other
gains/losses)
£
-
-
-
-
-
-
-
20,000
20,000
35,169
55,169		 Resources
expended
£		 Gross
transfers
£
-
-
-
-
-
-
-
-
-
18,015
18,015		 At 31
March
2021
£
500
15,000
1,000
1,000
210
200
105
20,000
Restricted funds:
Restricted income funds:
Aylesford Family Trust
Roger Counter Foundation
W E Dunn Trust None
Albert Hunt Trust
Alex Duthie
Help Charity Shop
Christmas appeal
The People's Postcode Trust
Total
Unrestricted funds:
General funds
Revaluation Reserves:
Total funds
-
-
-
-
-
-
-
-
-
(34,382)
(34,382)
38,015
13,313
51,328

Purposes and restrictions in relation to the funds: Restricted funds: Aylesford Family Trust Roger Counter Foundation W E Dunn Trust None Albert Hunt Trust Alex Duthie Help Charity Shop Christmas appeal The People's Postcode Trust

Page 14

Race Against Blood Cancer Notes to the Accounts

13 Analysis of net assets between funds

Net current assets
Creditors due in more than one year and
provisions
14 Reconciliation of net debt
Cash and cash equivalents
Bank loans
Net debt		 At 1 April
2020
£		 Unrestricted
funds
£
63,328
(12,000)
51,328
Cash flows
£		 Total
£
63,328
(12,000)
51,328
At 31
March
2021
£
31,484 33,769 65,253
31,484
-
-
31,484		 33,769
(15,000)
(15,000)
18,769		 65,253
(15,000)
(15,000)
50,253
15 Commitments
Operating lease commitments
Annual commitments under non-cancellable operating leases
2021
Land and
buildings
£
Operating leases with expiry date:
Pension commitments
The pension cost charge to the company
amounted to:		 are as follows:
2021
Other
£
2021
£
593		 2020
Land and
buildings
£		 2020
Other
£
2020
£
750

16 Related party disclosures

Controlling party

The company is limited by guarantee and has no share capital; thus no single party controls the company.

Page 15

Race Against Blood Cancer Detailed Statement of Financial Activities

for the year ended 31 March 2021

Income and endowments from:
Donations and legacies
Adhoc Donations MyDonate
Donations From Events
General Donations
Regular Donations
Other
Government JRS Grant
Total income and endowments
Expenditure on:
Costs of generating donations and
legacies
Adhoc Donations MyDonate
Donations From Events
Total of expenditure on raising
funds
Employee costs
Salaries/wages
Employer's NIC
Pension costs
General administrative costs,
including depreciation and
amortisation
General insurances
Postage and couriers
Software, IT support and related
costs
Sundry expenses
Telephone, fax and broadband
Legal and professional costs
Accountancy and bookkeeping
Consultancy fees
Total of expenditure of other costs		 Unrestricted
funds
2021
£
1
10,463
8,212
152
18,828
16,341
16,341
35,169
1,457
559
2,016
2,016
25,924
-
593
26,517
482
278
441
977
366
2,544
700
2,605
3,305
32,366		 Restricted
funds
2021
£
-
-
20,000
-
20,000
-
-
20,000
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-		 Total funds
2021
£
1
10,463
28,212
152
38,828
16,341
16,341
55,169
1,457
559
2,016
2,016
25,924
-
593
26,517
482
278
441
977
366
2,544
700
2,605
3,305
32,366		 Total funds
2020
£
70
25,398
33,969
3,115
62,552
-
-
62,552
1,783
17,275
19,058
19,058
32,255
3,030
750
36,035
194
-
203
1,897
432
2,726
278
4,961
5,239
44,000

Page 16

Race Against Blood Cancer Detailed Statement of Financial Activities

Race Against Blood Cancer
Detailed Statement of Financial Activities
Total expenditure
Net gains on investments
Net income/(expenditure)
Transfers between funds
Net income/(expenditure) before
other gains/(losses)
Other Gains
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward		 34,382
-
787
18,015
18,802
-
18,802
(5,489)
13,313		 -
-
20,000
-
20,000
-
20,000
18,015
38,015		 34,382
-
20,787
18,015
38,802
-
38,802
12,526
51,328		 63,058
-
(506)
(6,893)
(7,399)
-
(7,399)
19,925
12,526

Page 17